SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Copp DH, Davidson AGF, Cheney BA 1961 Evidence for a new parathyroid hormone which lowers blood calcium. Proc Can Fed Biol Soc 4: 17.
  • 2
    Copp DH, Cameron EC, Cheney BA, Davidson AGF, Henze KG 1962 Evidence for calcitonin-a new hormone from the parathyroid that lowers blood calcium. Endocrinology 70: 638649.
  • 3
    Hirsch PF, Gauthier GF, Munson PL 1963 Thyroid hypocalcaemic principle and recurrent laryngeal nerve injury as factors affecting response to parathyroidectomy in rats. Endocrinology 73: 638649.
  • 4
    Jacobs JW, Goodman RH, Chin WW, Dee PC, Habener JF, Bell NH, Potts JT Jr 1981 Calcitonin messenger RNA encodes multiple polypeptides in a single precursor. Science 213: 457459.
  • 5
    Amara SG, Jonas W, Rosenfeld MG, Ong ES, Evans RM 1982 Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240244.
  • 6
    Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM 1983 Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304: 129135.
  • 7
    Lu JT, Son YJ, Lee J, Jetton TL, Shiota M, Moscoso L, Niswender KD, Loewy AD, Magnuson MA, Sanes JR, Emeson RB 1999 Mice lacking α-calcitonin-gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci 14: 99120.
  • 8
    Ballica R, Valentijn K, Khachatryan A, Guerder S, Kapadia S, Gundberg C, Gilligan J, Flavell RA, Vignery A 1999 Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice. J Bone Miner Res 14: 10671074.
  • 9
    Hirsch PF, Lester GE, Talmage RV 2001 Calcitonin, an enigmatic hormone: Does it have a function. J Musculoskel Neuron Interact 4: 299305.
  • 10
    Hoff AO, Catala-Lehnen P, Thomas PM, Priemel M, Rueger JM, Nasonkin I, Bradley A, Hughes MR, Ordonez N, Cote GJ, Amling M, Gagel RF 2002 Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest 110: 18491857.
  • 11
    Zaidi M, Moonga BS, Abe E 2002 Calcitonin and bone formation: A knockout full of surprises. J Clin Invest 110: 17691771.
  • 12
    Ducy D, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100: 197207.
  • 13
    Sexton PM 1992 Central nervous system binding sites for calcitonin and calcitonin gene-related peptide. Mol Neurobiol 5: 251273.
  • 14
    Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305317.
  • 15
    Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB 1999 Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of a normal mineral ion homeostasis: Formal histomorphometric and biochemical analyses. Endocrinology 140: 49824987.
  • 16
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols and units. J Bone Miner Res 2: 595610.
  • 17
    Imai S, Matsusue Y 2002 Neuronal regulation of bone metabolism and anabolism: Calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone. Microsc Res Tech 58: 6169.
  • 18
    Irie K, Hara-Irie F, Hidehiro O, Yahjima T 2002 Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech 58: 8589.
  • 19
    McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM 1998 RAMPs regulate the transport and ligand specifity of the calcitonin-receptor-like receptor. Nature 393: 333338.
  • 20
    Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM 2002 International union of pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233246.
  • 21
    Konttinen YT, Imai S, Suda A 1996 Neuropeptides and the puzzle of bone remodelling: State of the art. Acta Orthop Scand 67: 632639.
  • 22
    Foster GV, Baghdiantz A, Kumar MA, Slack E, Soliman HA, MacIntyre I 1964 Thyroid origin of calcitonin. Nature 202: 13031305.
  • 23
    Friedmann J, Raisz LG 1965 Thyrocalcitonin: Inhibitor of bone resorption in tissue culture. Science 150: 14651467.
  • 24
    Foster GV, MacIntyre I, Pearse AGE 1965 Calcitonin production and the mitochondrion-rich cells of the dog thyroid. Nature 203: 10291031.
  • 25
    Pearse AGE 1966 5-Hydroxytryptophan uptake by dog thyroid “C” cells, and its possible significance in polypeptide hormone production. Nature 211: 598600.
  • 26
    Neher R, Riniker B, Maier R, Byfield PG, Gudmundsson TV, MacIntyre I 1968 Human calcitonin. Nature 220: 984986.
  • 27
    Singer FR 1977 Human calcitonin treatment of Paget's disease of bone. Clin Orthop 127: 8693.
  • 28
    MacIntyre I, Whitehead MI, Banks LM, Stevenson JC, Wimalawansa SJ, Healy MJR 1988 Calcitonin for prevention of postmenopausal bone loss. Lancet 23: 900901.
  • 29
    Body J-J 2002 Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis. Bone 30: 75S79S.
  • 30
    Zaidi M, Inzerillo AM, Moonga BS, Bevis PJR, Huang CL-H 2002 Forty years of calcitonin-where are we now? A tribute to the work of Iain MacIntyre, FRS. Bone 30: 655663.
  • 31
    Villa I, Melzi R, Pagani F, Ravasi F, Rubinacci A, Guidobono F 2000 Effects of calcitonin gene-related peptide and amylin on human osteoblast-like cells proliferation. Eur J Pharmacol 409: 273278.
  • 32
    Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, Cooper GJ, Reid IR 1999 Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J Bone Miner Res 14: 13021309.
  • 33
    Valentijn K, Gutow AP, Troiano N, Gundberg C, Gilligan JP, Vignery A 1997 Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone 21: 269274.
  • 34
    Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC 2004 β-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong osteoporosis study. J Bone Miner Res 19: 1924.
  • 35
    Oh-hashi Y, Shindo T, Kurihara Y, Imai T, Wang Y, Morita H, Imai Y, Kayaba Y, Nishimatsu H, Suematsu Y, Hirata Y, Yazaki Y, Nagai R, Kuwaki T, Kurihara H 2001 Elevated sympathetic nervous activity in mice deficient in αCGRP. Circ Res 89: 983990.
  • 36
    Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG 1985 Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229: 10941097.
  • 37
    Muff R, Born W, Fischer JA 1995 Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: Homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 133: 1720.